LNA043 clinical trials

A 5- year randomized, double-blind, placebo-controlled, multi-center study assessing the efficacy, safety, and tolerability of intra-articular regimens of LNA043 versus placebo in patients with symptomatic knee osteoarthritis (ONWARDS)

This 5-year study is looking at a new medicine, LNA043, for knee osteoarthritis. It compares LNA043 to a dummy treatment (placebo) to see if it improves knee structure and reduces pain and stiffness for people aged 18 and over.